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Abstract.  We have isolated vesicles that mediate pro- 
tein transport from the ER to Golgi membranes in 
perforated yeast. These vesicles, which form de novo 
during in vitro incubations,  carry lumenal and mem- 
brane proteins that include core-glycosylated pro- 
~x-factor, Betl, Sec22, and Bosl, but not ER-resident 
Kar2 or Sec61 proteins.  Thus,  lumenal and membrane 
proteins in the ER are sorted prior to transport vesicle 
scission.  Inhibition of Yptlp-function,  which prevents 
newly formed vesicles from docking to cis-Golgi 
membranes,  was used to block transport.  Vesicles that 
accumulate are competent for fusion with cis-Golgi 
membranes, but not with ER membranes,  and thus are 
functionally committed to vectorial transport.  A  900- 
fold enrichment was developed using differential cen- 
trifugation and a  series of velocity and equilibrium 
density gradients.  Electron microscopic analysis shows 
a uniform population of 60 nm vesicles that lack pe- 
ripheral protein coats.  Quantitative Western blot anal- 
ysis indicates that protein markers of cytosol and cel- 
lular membranes are depleted throughout the 
purification,  whereas the synaptobrevin-like Betl, 
Sec22, and Bosl proteins are highly enriched. 
Uncoated E___RR-derived  transport vesicles (ERV) contain 
twelve major proteins that associate tightly with the 
membrane.  The ERV proteins may represent abundant 
cargo and additional targeting  molecules. 
M 
ORPHOLOGICAL  analysis of eukaryotic cells led to 
the  hypothesis  that  small  vesicles  mediate  the 
directional  transport of proteins between succes- 
sive  organelles  of the  secretory  pathway  (Jamieson  and 
Palade,  1967; Palade,  1975). The machinery that catalyzes 
vesicular transport  is now being studied at the molecular 
level using in vitro assays that reconstitute intercompartmen- 
tal protein transport in perforated cells and membrane ex- 
tracts (Pryer et al.,  1992). The characterization  of vesicles 
that mediate intercompartmental  protein transport in vitro 
will help address the role of integral membrane proteins that 
function in vesicular traffic. 
Although most transport vesicles are transient  intermedi- 
ates,  they can be forced to accumulate as stable intermedi- 
ates when a component of the vesicle targeting machinery is 
inactivated.  Most transport vesicles are 50-100 nm in size 
and may be coated with a peripheral protein lattice. In coated 
transport vesicles, the subunits of the coat are the most abun- 
dant proteins  in pure vesicle preparations.  Clathrin  com- 
plexes coat vesicles derived from the trans-Golgi and plasma 
membranes (Brodsky,  1988).  Assembly of clathrin  lattices 
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onto the donor membrane is guided by adaptins  and ADP 
ribosylation  factor (ARF)  t proteins,  and functions  to select 
a cargo of membrane proteins,  and to drive vesicle budding 
(Pearse and Robinson,  1990; Keen,  1990;  Stamnes et al., 
1993). On the other hand, nonclathrin  coatomer complexes 
coat vesicles derived from Golgi membranes (Malhotra et 
al., 1989). Assembly of coatomer onto membranes is guided 
by ARF and functions to drive the membrane shape change 
that accompanies budding (Palmer et al., 1993; Orci et al., 
1993). In both cases,  coats disassemble prior to vesicle fu- 
sion with the target membrane (Brodsky,  1988; Orci et al., 
1989).  Most  proteins  in  uncoated  transport  vesicles  are 
tightly  associated with  the membrane.  For  example,  un- 
coated synaptic vesicles contain various integral  membrane 
proteins with distinct structural  features;  the most abundant 
are termed synaptobrevin,  synaptophysin,  and synaptotag- 
min (Stidhof and Jahn, 1991). These membrane proteins are 
thought to promote vesicle targeting or fusion to the plasma 
membrane. 
Insight  into  the components and  mechanics  of vesicle- 
mediated protein  transport  has  been provided by genetic 
analysis of the yeast Saccharomyces cerevisiae. More than 25 
1. Abbreviations  used in this paper: ARF, ADP ribosylation factor; CPK, 
creatine phosphokinase; E  Ficoll;  core-gp~f,  core-glycosylated  pro-c~- 
factor; MSS, medium speed supernatant fraction; p~f, pro-c~-factor; pp~, 
pre-pro-e~-factor; 8, sucrose. 
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port have been identified (Pryer et al., 1992) and their func- 
tion tested  using temperature-sensitive  mutants,  or by de- 
pleting cells of the protein in question. Cells that contain a 
mutant form of Secl2, Secl3, Secl6, or Sec23 proteins are 
blocked in ER to Golgi protein transport and accumulate en- 
larged ER membranes (Novick et al.,  1980;  Novick et al., 
1981;  Kaiser  and  Schekman,  1990).  These  proteins  are 
thought to function in the formation of ER-derived transport 
vesicles. In contrast, cells that contain a mutant form of Ypfl, 
Sec22, Sec18, or Secl7, and cells depleted  of Bosl or Set5 
proteins  are deficient  in protein transport from ER to the 
Golgi membranes  and accumulate 50-60 nm vesicles and 
enlarged ER membranes (Kaiser and Schekman,  1990; Shim 
et al.,  1991;  Becker  et al.,  1991; Hardwick  and Pelham, 
1992). Because these cells accumulate small vesicles, these 
proteins are thought to function in the targeting or fusion of 
ER-derived transport vesicles. 
The function of proteins identified in genetic screens can 
be tested directly  using in vitro assays that reconstitute  ER 
to Golgi protein transport in perforated yeast spheroplasts or 
microsomal preparations (Baker et al., 1988; Ruohola et al., 
1988).  Subassays  that measure vesicle budding,  targeting, 
and fusion have allowed a direct assessment of the protein, 
nucleotide, and ionic requirements  for each stage (Rexach 
and  Schekman,  1991).  The  release  of vesicles  from  ER 
membranes requires GTP and the function of Sec12p, Sarlp, 
Sec23/24p complex,  and Secl3/31p  complex (Rexach  and 
Schekman,  1991;  Oka and Nakano,  1991;  d'Enfert et al., 
1991; Hicke et al.,  1992; Barlowe et al.,  1993a,b; Pryer et 
al.,  1993;  Salama et al.,  1993).  The stable attachment  of 
transport vesicles to Golgi membranes requires the function 
of Yptl and Secl 8 proteins,  whereas fusion between vesicle 
and the cis-Golgi membranes  requires calcium and ATP at 
physiological temperature  (Rexach  and  Schekman,  1991). 
Specific antibodies against Sec7p and Boslp block vesicle tar- 
geting  or fusion (Franzusoff et al.,  1992;  Lian and Ferro- 
Novick,  1993). 
Here  we report the purification  of ER-derived  transport 
vesicles that accumulate in vitro when perforated yeast ceils 
of a Yptlp-deficient strain are incubated with cytosol and an 
ATP regeneration  system at physiological temperature.  We 
examined the function and molecular composition of puri- 
fied  transport  vesicles,  and  provide  a  direct  biochemical 
demonstration that diffusible vesicles mediate selective and 
vectorial transport of lumenal and membrane proteins from 
the endoplasmic reticulum  to the Golgi complex. 
Materials and Methods 
The yeast strains used in this study were RSY 445 (leu 2-3d12; ura 3-52; 
trpl-289; prbl, pep4: :  URA3; gal2; his 4-579, MATc0, RSY 607 (ura3-52; 
leu2-3d12;  pep4::URA3;  MATe0, RSY  453  (ypt/e:LEU2,  glsl-1; leu2; 
his3, ura3-52; MATs), RSY 1001 (yptl~:LEU2; glsl-l; leu2; his3; ura3-52; 
pep4::URA3;  MATs)  and  MLY  1601 yptl"::LEU2  (glsl-1, 1eu2-3,112, 
ura3-52, pep4:: URA3  ). 
Preparation of Perforated Yeast  Spheroplasts 
Cells were grown at 30°C (wild-type) or 24°C (ypd ts) in YP medium (1% 
Bacto yeast extract, 2% Bacto peptone; Difco Laboratories Inc., Detroit, 
MI), and 5% glucose to early log phase (2--40Du~o/ml; 10D U is 107 
cells). Approximately 2,000 OD60o cells were harvested by centrifugation 
at 5,000 rpm for 5 rain in a GSA Sorvall rotor chilled to 4°C.  Cells were 
resnspended to 50 OD60o/ml in 10 mM Tris, pH 9.4,  10 mM DTT and in- 
cubated for 5 win at room temperature. Cells were sedimented at 2,000 g 
for 5 rain at room temperature in a clinical centrifuge and resuspended to 
50 ODu)o/ml in spbemplasting medium (0.75×  YP, 0.7 M sorbitol, 0.5% 
glucose,  10 mM Tris, pH 7.5). The initial integrity of the cell wall was deter- 
mined by diluting an aliquot of cells 1:100 in water,  and measuring the 
OD60o after 1 rain. Lyticase  was  mixed with the cells (30 U/OD60o for 
wild-type,  and 60 U/OD60o for ypt/ts) and incubated at 24°C (ypd ts) or 
300C (wild-type)  until the OD60o readings  of cell aliquots  were less than 
10% of the initial OD(,0o value.  Spberoplasts  were sedimented at 2,000 g 
for 5 rain as before,  resuspended to 50D600/ml in regeneration medium 
(0.75× YP, 0.7 M sorbitol, 1% glucose), and incubated with gentle shaking 
during 30 win at 240C (ypt/ts) or 300C (wild-type).  Spheroplasts were bar- 
vested by centrifugetion at 5,000 rpm for 5 rain at 4*(2 in a Sorvail GSA 
rotor, and resnspended to 100 OD60o/ml in lysis buffer (20 mM Hepes, pH 
6.8, 400 mM sorbitol, 150 mM KOAc, 2 mM MgOAc, 0.5 mM EGTA). 
Cells were transferred to a 40 ml Sorvall ultracentrifuge tube  and sedi- 
mented at 6,000 g for 5 rain at 40C in a Sorvall SS34 rotor. For small-scale 
perforated  cell preparations, we resuspended spheroplasts to 300 OD60o/ 
ml in lysis buffer, aliquoted them in 200/d portions into L5 rni microcen- 
trifuge tubes, and froze them by suspension over liquid nitrogen vapor for 
30 rain (see Baker et al., 1989). For large-scale perforated cell preparations, 
we resnspended spheroplasts to 100 OD6oo/ml, sedimented them as before, 
and froze them as a cell pellet by storing at -70"C. After thawing, spbero- 
plasts were perforated using low osmotic support buffer  (see below). 
Preparation of  Membrane-free Cytosol 
Cells were grown at 24°C (ypd ts) or 30°C (wild-type) in YP medium, 5% 
glucose  to log  phase (5-10  OD6oo/ml), and ~,6,000  OD~oo cell  units  were 
harvested  by  centrifugation  at  5,000  rpm for  5 win  at  4°C in  a  Sorvall  GSA 
rotor. All subsequent steps were carried out at 40C. Cells were resuspended 
in 60 nd distilled water and washed twice by sedimentation at 6,000 g for 
5 rain and dilution in distilled water.  Cell pellets were frozen at -70°C. 
Thawed cell pellets were washed once with B88 (20 mM Hepes,  pH 6.8, 
150 mM KOAc, 250 mM sorbitol, 5 mM MgOAc), resuspended in 60 ml 
of B88, and 20 ml portions (2,000 OD~,oo U) aliquoted into Corex 30 ml 
glass tubes. Cells were sedimented as before and to each tube, 4 g of glass 
beads (0.5-ram diana) and 1 ml of solution A (20 mM Hepes,  pH 6.8, 50 
mM KOAc, 100 mM sorbitol, 5 mM MgOAc, 1 mM ATP, 0.5 mM PMSF, 
1 mM DTT) were added. Cells were lysed by 6 ×  30 s periods of agitation 
in a VWR vortexer (Scientific Industries, Inc., Bohemia, NY) at full speed, 
with l-rain incubations on ice in between periods. To each sample,  1.5 ml 
of solution B (20 mM Hepes,  pH 6.8, 2 M KCI, 400 mM sorbitol, 5 mM 
MgOAc, I mM ATE 0.5 mM PMSF, 1 mM DTT) was added and tubes were 
vortexed 3 × 30 s at full speed. The homogenate was clarified by centrifuga- 
tion at 12,000 g for 5 rain in a Sorvnll SS34 rotor. The combined superna- 
rants (9 mi) were mixed with an equal volume of 80% Nycodenz,  20 mM 
Hepes, pH 6.8, 150 mM KOAc, 5 mM MgOAc, and transferred  into two 11.5 
1111 Ultraclear tubes (Beckman Instruments, Palo Alto, CA) and overlaid 
with 2.5 ml 20 mM Hepes, pH 6.8, 150 mM KOAc, 5 mM MgOAc. The 
tubes were centrifuged  for 21 h at 35,000 rpm in a SW41 Beckman rotor. 
Cytosol (7.5 ml) was slowly drained from the bottom of each tube, avoiding 
the  membranes  and  lipid  particles  that  accumulate  in  the  40%/0% 
Nycodenz interface.  The cytosol pool (15 ml) was applied to the bottom of 
a top-fitted Sephadex medium G-25 desalting column (80 mi packed resin) 
equilibrated in B88, 1 mM ATP. The sample was pumped upwards at a flow 
rate of 1 ml/min using a Rainln Rabbit pump 0Noburn, MA), and fractions 
collected from the top. The eluted protein peak was pooled, nliquoted,  fro- 
zen in liquid nitrogen, and stored at -70°C. Protein concentration was usu- 
ally 9 mg/ml, and was measured by the Bradford protein assay and com- 
pared to a BSA standard. 
In Vitro Transport 
Reagents used for the in vitro transport assay were obtained as described 
in Baker et al. (1988, 1989) unless otherwise indicated. 
Stage I: Ttm~/ocat/on. FOr each experiment a frozen aliquot of perfo- 
rated yeast spheroplasts  (Fig. 60 ODe0o U of cell equivalents) was thawed 
and washed once by dilution in B88 and sedimented at 13,000 g for 40 s 
in a refrigerated  microcentrifuge (Tomy Tech USA Inc., Palo Alto, CA). 
The cell pellet was resuspended in 1 ml low osmotic support B88 (20 mM 
Hepes, pH 6.8, 50 mM KOAc, 250 mM sorbitol, 5 mlvl MgOAc) to max- 
imize spberoplnst lysis (>90% perforated). After I rain at 4°{2, membranes 
were sedimented, washed once with B88 as before, and resnspended in 0.1 
ml  of a  yeast  S-100 translation lysate  that contained [35S]methionine- 
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et al., 1988) in final volumes of 160 p,1. The final concentration of compo- 
nents in a 25-~1 translocation reaction was 75 ~g of membranes (measured 
by the amido-black protein assay described in the Materials and Methods), 
90/tg of yeast S100 lysate (measured by the Bradford protein assay), 50/tM 
GDP-mannose, 1 mM ATP, 40 mM creatine phosphate (CP), and 200/tg/ml 
creatine phosphokinase (CPK), all dissolved in B8& The mix was incubated 
15 rain at 10°C to allow posttranslational translocation of ppaf, chilled to 
4°C, diluted with 1 mi B88, and sedimented as before. Membranes were 
resnspended in 1 mi of high-salt B88 (20 mM Hepes, pH 6.8,  1 M KOAc, 
250 mM sorbitol, 5 mM MgOAc) and rotated at 4°C for 7 mill. Membranes 
were sedimented, washed once with B88 and the final membrane pellet 
resnspended to 160 ~l (30 ~g/10 ~). 
Stage II: Transport.  Each transport reaction (25 ~d) contained 10 #1 of 
stage I membranes, 90/~g of membrane-free cytosol, 1 mM ATP, 50 #M 
GDP mannose, 40 mM CP, 200/~g/mi CPK, in B8& For time courses, a 
200/~1 stage II mix was prepared and aliquoted in 25-#1 portions into 0.5 
mi microcentrifuge robes. Reactions were incubated at 0 ° or 25°C for the 
indicated times, each robe represented one time point. Reactions were ter- 
minated by placing each tube on ice until the last time point was taken. All- 
quots (15 ~1) of each time poim were treated with 10 ~1 of a trypsin solution 
(625  ~g/ml in B88) for 10 rain on ice, and then with 10 ~1 of a trypsin 
inhibitor solution (1.25 rag/m1 in B88), for 10 rain on ice. Each sample re- 
ceived 45/~I of 2 x  Laemmli sample buffer without reducing agent, and was 
heated at 95°C for 10 min. Equal aliquots of each robe were treated with 
either Con A-Sepharose, or protein A-Sepharose coupled with anti-cd,6 an- 
tibody as described by Baker et al.  (1988).  Washed immunoprecipitates 
were heated to 95°C in 1% SDS for 5 rain and dissolved in Universol ES 
scintillation fluid (1CN Biomedicals, Irvine, CA) for quantitation in a scin- 
tillation counter. Glycosylated forms of a-factor am the major radiolabeled 
proteins. 
Stage 111." Transport Vesicle Chases. Aliquots (5 pl) of  purified transport 
vesicles or pool 1 fractions were mixed with membrane-free  cytosol, perfo- 
rated wild-type yeast spheroplasts or microsomes, and an ATP regeneration 
system, to the same concentrations as for stage H of transport (see above) 
in a total volume of 50/~1.  Chases were conducted for 1 h at 0 ° or 20°C 
in the presence of various additions (i.e., cytosol, membranes, ATP). Reac- 
tions were terminated by the addition of 50 ~1 of  2 x  Laemmli sample buffer 
without reducing agent, and were processed for their content of glxff  as de- 
scribed for stage II transport. 
Vesicle Budding and Fusion Assay 
Stage II transport reactions were terminated by placing tubes on ice (see 
above), and each tube was fractionated by centrifugation for 40 s at 13,000 
rpm in a  refrigerated microcentrifuge (Tomy  Tech USA Inc.).  A  15-/~1 
medium speed supernatant fraction (MSS) was taken from the meniscus and 
treated with trypsin and trypsin inhibitor, then mixed with Laemmli sample 
buffer without reducing agent, and aliquots processed for Con A and cd,6 
antibody precipitation as for stage H transport. A  15-/d aliquot of unfrac- 
tionated reactions is referred to as total, and served to calculate the =% 
release" of  protein markers from perforamd cells. Budding efficiency is ex- 
pressed as the percentage of  protease protected gp~f/#l of the MSS fraction 
over pmtease protected gpcd//~l of the total fraction. 
ER-Protein Sorting Assay 
To measure the release or retention of lumenal ER-proteins, vesicle budding 
assays ware performed as described above, with 2 % beta-mereaptoethanol 
Cg-ME) included in the Laemmli sample buffer. To measure the release or 
retention of membrane embedded ER-proteins, vesicle budding assays were 
performed in  the  absence of radiolabeled  [35S]-pro-c¢-factor  (an  S100 
translation iysate without radiolabeled pre-pro-cx-factor  was used for Stage 
1). After samples were fractionated in a microcentrifuge, they were mixed 
with 25 ~1 of 2x Laemmli buffer with 2 % ~-ME, and heated at 65°C for 
15 min. Aliquots (15 ~1) were subjected to SDS-PAGE in 14% acrylamide 
mini-gels, and [125I]-Pmtein A western blots were performed as described 
below. 
ER-Membrane Fusion Assay 
Aliquots (5 tzl) of an enriched transport vesicle preparation (from pool 1) 
were mixed with 100/~g of wild-type membrane-free  cytosol, 25/~g of  wild- 
type yeast microsomcs (prepared as in ~estehube and Schekman, 1992), 
and an ATP regeneration system, in a total volume of 50/~1.  Chases were 
conducted for 1 h at 0 ° or 20°C in the presence of various additions (i.e., 
GDP-mannose, ¢ytosol, Triton X-100). Chilled reactions were treated with 
trypsin and then trypsin inhibitor (as for stage II transport)  to degrade gpod 
that was not membrane enclosed. ~ons  were terminated by the addition 
of 60/~1 of2x Laemmli sample buffer without reducing agent and samples 
were processed for their content of gpcd as described for stage II transport, 
or mixed with 2% fl-ME and resolved in a 12.5% SDS-PAGE. Gels were 
fixed, dried, and exposed to phosphor plates. The percentage of glucose 
trimming (i.e., the conversion of the 32-kD g/s/-1 form of core-gpoff  to the 
29-kD wild-type form) was quantified using standard software in a Molec- 
ular Dynamics PhosphorImager (Sunnyvale, CA). For a more detailed de- 
scription of the ER-membrane fusion assay see Latterich and Schekman 
(1994). 
Vesicle-targeting~Docking  Assay 
Membranes released from perforated cells during stage II incubations ware 
subjected to velocity sedimentation in a Ficoll (F)/sucrose (s) gradient that 
resolves diffusible vesicles from cis-Golgl membranes. Stage II reactions 
(400/tl) were incubated 35 rain at 25°C and then chilled. MSS fractions 
(300 ~) were obtained after sedimentmg  perforated  cells at 13,000  g for 
90 s at 4°C. Each MSS fraction was loaded into a 5 ml Beckman Ultraclear 
tube that contained 600 ~1 of 60% s (wt/vol)/5% F (wt/vol) at the bottom, 
layered with 1 mi of 4% F/15%  s, 1 mi 3% F/15% s, 1 ml 2% F/15% s, 
and 1 ml 1% F/15 % s all dissolved in reaction buffer without sorbitol. Tubes 
were centrifuged 2 h at 35,000 rpm in a Beckman SW 50.1 ultracentrifuge 
rotor. 18 aliquots (300 ~tl) were collected from the top using a gradient col- 
lector (1sco Inc., Lincoln, N-EL Fractions were analyzed for their content 
of GDPase activity, refractive index, and content of radioactive glxff. 
Vesicle Purification 
A pellet of frozen yeast spheroplasts (2,000 ODt00  U of cell equivalents; 
see preparation of perforated yeast spheroplasts) was thawed, and washed 
once by dilution in chilled B8& Spheroplasts were sedimented at 12,000 g 
for 2  min  at  4°C  in a  SorvaU  SS34  rotor,  and  the pellet  (1  ml)  was 
resuspended in 2 ml of B88. The sample was mixed with 15 ml of low os- 
motic support B88 (20 mM Hopes, pH 6.8, 50 mM KOAc, 250 mM sorbitol, 
5 mM MgOAc), and allowed to stand at 4°C for 1 rain to allow spheropiast 
lysis; lysis was stopped by mixing the sample with 2 ml of high-salt B88 
(20 mM Hepes, pH 6.8, 1 M KOAc, 250 mM sorbitol, 5 mM MgOAc). Per- 
forated cells were washed with B88, the pellet was resuspended in 1 ml of 
B88, and the cell suspension was mixed with 1-3 ml of  a yeast S-100 transla- 
tion lysate that contained [35S]methionine-ppod,  and with 0.4 to 0.6 rill of 
a 10x ATP regeneration mix (Baker et al., 1988) in final volumes of 4 to 
6 ml. The mix was incubated for 20 rain at 10°C to allow posttranslational 
translocation (stage 1),  and chilled for  10 rain at 4°C.  The sample was 
diluted to  15 ml with B88, sedimented as before, and membranes resus- 
pended in 10 ml of high-salt B88 and allowed to chill for 10 rain with occa- 
sional swirling. Membranes were again sedimented, washed once with B88, 
and resuspended to 5.3 mi with Bg& The membrane suspension was mixed 
with 5 ml of membrane-free cytosol (9 mg/ml), 1.32 ml of 10×  ATP re- 
generation mix, and 1.6 ml of Bg8 to a final volume of 13.2 ml. The con- 
centration of components was the same as described for stage II Transport. 
This mix is referred to as total, and was incubated 30 rain at 25°C avoiding 
agitation of the sample. The reaction was chilled for 15 rain, and a  12 ml 
MSS fraction was taken after sedimenting perforated cells at 12,000 g for 
2 rain at 4°C. All subsequent steps were carried out at 4°C. The MSS frac- 
tion was loaded in a  17 ml Ultraclear Beckman tube that contained 2 mi 
of 30% sucrose (wt/vol) layered on top of 2.5 ml of 60% sucrose, both dis- 
solved in B88 without sorbitol. This tube, referred to as VS I, was subjected 
to overnight centrifugation (16 h) at 25,000 rpm in a Beckman SW41 rotor. 
The gradient was collected from the top at a rate of 0.3 ml/min using a gra- 
dient collector (Isco Inc.) and 9 x  1.5 ml fractions, followed  by 30 x  0.2-ml 
fractions, were dispensed into  sfliconized microcentrifuge tubes (Sigma 
Chemical Co., St. Louis, MO). The absorbance at 280 nm was measured 
with a spectrophotometer (Isco, Inc.) attached to a 2 nun top-fitted flow 
cell. Aliquots (5/~1) of each fraction were mixed with 0.5 ml of water, and 
then with 5 ml of Universol ES scintillation fluid (1CN Biomedicals), and 
the radioactivity quantified in a Beckman scintillation counter. The peak of 
radioactivity, always centered around a density of 30% sucrose (wt/wt) was 
pooled (pool  1),  avoiding fractions with a  density above 32%  sucrose 
(wt/wt). Pool 1 was adjusted to a density of 15 % sucrose (wt/wt) by adding 
B88 without sorbitol. The diluted sample was loaded onto a 5 mi Ultraclear 
Beckman tube that contained a linear F gradient (prepared by layering 0.85- 
mi aliquots of 1% F/15% s, 2% F/15% s, 3% F/15% s, and 4% F/15% s, 
on top of 0.6 mi of 5 % F/60% s, all dissolved in B88 without sorbitol, and 
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subjected to centrifugation for 2 h at 40,000 rpm in a Beckman SW 50.1 
rotor. The gradient was collected from the top as before, and 27  x  0.2-ml 
aliquots were collected into siliconized microcentrifuge tubes. The radioac- 
tivity in 5-/zl aliquots of each sample was quantified as before. The peak 
of radioactivity was pooled (130012) adjusted to a density of 35% Nycodenz 
(wt/vol) by adding an equal volume of 80%  Nycodenz, dissolved in B88 
without sorbitol. The diluted sample was loaded in the bottom of a 5 ml 
Beckman Ultraclear tube, and layered with 0.7 mi aliquots of 30, 25,  20, 
15, and 10%  Nycodenz, all dissolved in B88 without sorbitol. This tube, 
referred to as EQ, was subjected to overnight centrifugation (16 h) at 40,000 
rpm in a Beckman SW50.1 rotor. The gradient was collected as before, and 
18 x  0.3-ml fractions were collected into siliconized  microcentrifuge tubes. 
Aliquots (5/zl) were analyzed by scintillation counting, and the peak of ra- 
dioactivity was pooled (pool 3). 
Amido-black Protein Concentration Assay 
Samples containing 0.1 to 10/~g of protein were diluted to 0.25 ml with dis- 
tilled water, mixed with 0.03 ml of 1 M Tris, pH 7.5,  1% SDS, and then 
with 0.06 mi of 60% TCA (wt/vol). After 2 rain at room temperature, the 
samples were spotted onto a nitrocellulose filter that was pre-soaked in 6% 
TCA and assembled into a Sigma dot blotter fitted toa vacuum hose. Sample 
wells were rinsed once with 6% TCA.  Filters were removed from the dot 
blotter, rinsed with 6% TCA, and stained for 2-3 rain in 0.1% amido black 
dissolved in MeOH/HOAc/H20 (45:10:45).  The stained filter was rinsed 
with  distilled  water,  destained  in  MeOH/HOAc/H20  (270:6:24),  and 
soaked in distilled water. Protein spots were cut out and placed in siliconized 
microcentrifuge tubes that  contained 0.3  mi  of elution buffer (25  mM 
NaOH, 0.05 mM EDTA, 50% EtOH). After 20 rain, the absorbance was 
read  at  630  nm wavelength using a  spectrophotometer (perkin-Elmer, 
Corp., Norwalk, CT) fitted with 0.4 ml glass cuvettes. BSA was used as 
a standard protein to calculate sample concentrations. 
uJI-Protein A Western Blots and Quantitation 
in Phosphorlmager 
Proteins in Laemmli sample buffer were heated at 65 ° or 95°C, resolved 
in 9 or 14% polyacrylamide gels, and transferred to nitrocellulose or Bio 
Rad PDVF membranes using a Bio Rad semi-dry blotter (75 rain at 75 mA), 
or a minigel tank (Hoefer Scientific Instruments, San Francisco, CA) (2 h 
at 250 mA). Filters were stained with Ponceau S, rinsed in water, cut in 
sections, blocked with 2% milk in TBS-T for 30 rain, and incubated with 
primary antibodies for 90 rain. Blots were washed 4  x  7 min in TBS-T, 
and incubated with a 1:5,000 dilution of 125I-protein A for 1 h at room tem- 
perature. Blots were washed 4  x  7 rain, dried, and exposed to phosphor 
plates. The intensity of bands was quantified using standard software in a 
Pbosphorlmager (Molecular Dynamics). 
GDPase Enzyme Assay 
GDPase activity assays were performed as described in Yanagisawa etal. 
(1990).  Samples (5-20/~1) were mixed with 100/~1 of 20 mM imidazole- 
HCI, pH 7.4, 2 mM CaC12, 0.1% Triton X-100, and 10 mM GDP, or CDP 
as control. Tubes were incubated 30 min at 300C and reactions were termi- 
nated by adding 150 #1 of 2% SDS. Inorganic phosphate was quantified by 
the method of Friske-Subbarou. Samples were mixed with 750 t~l of a 6:1 
mix of 0.42% ammonium molybdate in 1 N H2SO4 and 10% ascorbic acid. 
The mix was incubated 20 rain at 45"C, and the absorbance at 820 or 750 
run was determined using a Perkin Elmer or a Bio-Tek Instruments (Burling- 
ton, VT) spectrophotometers, respectively. GDPase activity is expressed as 
arbitrary units equivalent to absorption value. 
TCA-DOC Protein Precipitation and Silver Stain Gels 
Samples were diluted to 1 ml with distilled water in microeentrifuge tubes, 
mixed with 0.1 ml of 0.15%  sodium deoxycholate, and then with 0.1 ml of 
72 % TCA. After 10 rain at room temperature, precipitates were sedimented 
at  15,000  g  for 15 rain at 4"C, the tubes were decanted, and the pellets 
washed with chilled (-20"C)  acetone.  Precipitates were recollected by 
sedimentation as before, the tubes were decanted, and the pellets were al- 
lowed to dry at room temperature. Pellets were finally resuspended in lx 
Laemmii sample buffer with 2% E-ME. Samples were heated to 65°C for 
15 rain, loaded in a 10 to 15% acrylamide-SDS gradient gel, and resolved 
by electrophoresis at 10-15 mA. Gels were fixed in 50% ethanol, 12% ace- 
tic acid, 0.02 % formaldehyde for 1 h at room temperature. Fixed gels were 
washed 3 x  10 min with 50% ethanol, incubated for 1 rain in 0.01% sodium 
thiosulfate, and then washed 3 x  15 s in distilled water. Gels were precoated 
for 20 rain in 0.1% silver nitrate, then washed 2  x  20 s in distilled water, 
and finally developed for 3-6 min in 3% sodium carbonate, 0.02%  formal- 
dehyde,  and  0.0002%  sodium  thiosulfate.  Developed gels  were  rinsed 
20 s in distilled water, and color development stopped by immersion and 
storage in 0.01 M  EDTA, pH 8.0. 
lmmunoisolation of  ER-derived Transport Vesicles 
Aliquots (20-60 ~1) of MSS fractions in 0.5 ml Eppendorf microcentrifuge 
tubes were incubated 1 h at room temperature with 1.25 #g of anti-Betl IgG 
or 0.5 ~tg of  affinity purified anti-Sec22p antibodies (kind gift of Dieter Gall- 
witz,  Max  Planck Institute of Biophysical Chemistry,  G6ttingen, Ger- 
many). Protein A-Sepharose beads (5-10 ttl of pecked beads) were added, 
and tubes rotated for 1 h at room temperature. Beads were sedimented for 
1 min at 2,000 rpm in a refrigerated microcentrifuge (Tomy Tech USA Inc.) 
and the superuatant fractions were saved. Beads were washed 4x with 0.4 
ml of B88 and the samples were transferred to clean tubes during the first 
and last washes to minimize background. After decanting the last wash, pro- 
teins were extracted from beads with  1%  Triton  X-100  in B88  or  Ix 
Laemmli sample buffer with or without reducing agent (2 %/3-ME). If Tri- 
ton extracted, beads were washed twice more with 1% TX-100 in B88, and 
the remaining proteins were extracted with Ix Laemmli sample buffer with 
2% /%ME at 70°C for 10 min. 
Electron Microscopy 
Negative Stain.  Samples (6 #1)  were spotted onto ionized copper grids 
that had a formvar support film stabilized by carbon, and were allowed to 
adsorb onto the film during a  15-rain  incubation at room temperature, in 
a humid chamber. Grids were washed gently in B88, and proteins were fixed 
during 15 rain with 1% gluteraldehyde dissolved in B88. Grids were washed 
in distilled water and spotted with 10/~1 of 2 % uranyl acetate. Excess stain 
was  removed and  the grids were allowed to dry at  room temperature. 
Stained particles were visualized and photographed using a  Philips 301 
electron microscope. 
Thin Section. Aliquots (250 #1) of purified vesicles from pool 3 were 
diluted to 1 ml with Bg8, and sedimented at 100,000 g for 1 h onto a "bed" 
of hardened low-melting agarose (1 tzl of 2.5%). After decanting, pellets 
were overlaid with 1% gluteraldehyde in B88 and allowed to fix for 1 h at 
4°C. Pellets were washed 2  x  5 min with 0.1 M sodium phosphate, pH 7.4, 
and 2  ×  5 min with 0.1 M  veronal-sodium acetate, pH 7.6. Pellets were 
stained for 1 h  at 4°C with  I%  osmium tetroxide dissolved in veronal- 
sodium acetate pH 7.6, and then washed 3  x  5 min with 0.05  M  sodium 
cacodylate, pH 7.0. Pellets were stained for 1 h at room temperature with 
1% tannic acid dissolved in cacodylate buffer and then washed 3  x  5 min 
with 0.05 M veronal-sodium acetate, pH 6.0. Pellets were then stained t  h 
at 37°C with 0.5% uranyl acetate in veronal acetate buffer, pH 6.0, and then 
washed 4  x  5 rain with distilled water. Samples were dehydrated in a series 
of ethanol solutions of increasing concentration, and finally in 100 % propy- 
lene oxide. Samples were embedded in low-viscosity Spurr resin, and al- 
lowed to polymerize overnight at 60"C. Silver/gold thin sections were cut 
and visualized using a Philips 301  electron microscope. 
Preparation of  Antibodies against Yptl and 
Betl Proteins 
Yptlp was overproduced in an F~cherichia coil strain (Segev etal., 1988), 
isolated in inclusion bodies, solubilized with 8 M urea, and dialyzed against 
0.1 M phosphate buffer, pH 7.4.  A solution of Yptl  protein (200 ~tg) was 
mixed 1:1 with Freund's complete adjuvant, and injected into rabbits. Rab- 
bits were boosted monthly with 50/tg of antigen dissolved in Freund's in- 
complete  adjuvant, and bled 2 wk after each injection. Anti-Yptlp serum was 
used at a dilution of 1:2,000 in Western blots. A synthetic peptide that con- 
tains the NH2-terminal 26 amino acids of Betlp with an added cysteinc at 
position 27 was used to prepare antibodies against Betlp. Betl peptide was 
conjugated to BSA in a 10:1 molar ratio using the DSP cross-linker. Con- 
jugates were gel filtered in a column that was equilibrated in 0.1 M phos- 
phate buffer at pH 7.4.  An aliquot of the conjugate (1 mg) was mixed 1:1 
with Freund's complete adjuvant, and injected into rabbits. Rabbits were 
boosted monthly, twice with 500/~g of  the conjugate in Freund's incomplete 
adjuvant, and twice more with 200 ~g of unconjugated peptide. Rabbits 
were bled 2 wk after each boost. Anti-Betlp serum was used at a dilution 
of 1:500 in western blots. IgO was purified using a protein A affinity matrix 
as described before (Hariow and Lane,  1988). 
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Figure  1.  ER-derived  trans- 
port  vesicles  accumulate  in 
ypt/ ts extracts.  (A) Stage II 
reactions  containing  wild- 
type (Sec  +) or ypt/ ts perfo- 
rated  ceils and  cytosol were 
incubated for 60 rain at 00 or 
25°C,  as  indicated.  Chilled 
reactions  were  treated  with 
trypsin and then trypsin inhib- 
itor. Samples were heated in 
1% SDS and the glycosylated 
pro-s-factor (gp~f) was quan- 
tiffed using precipitation with 
Con  A  and  anti-outer-chain 
antibodies as described in the Methods for stage II transport. (B) Stage II reactions containing wild-type (Sec  +) or ypd ts perforated cells 
and cytosol were incubated at 25°C for the indicated times, or at 0*C for the zero-time point control. Chilled samples were fractionated 
in a microcentrifuge into medium speed pellet and MSS fractions. MSS fractions were treated with trypsin and trypsin inhibitor, and 
processed for their content of gpa,  f as in A. The release of 3sS-gpotf  from perforated cells (vesicle budding) is plotted in the left panel 
and the appearance of outer chain gpaf in the MSS (vesicle fusion) is plotted in the right panel. The zero time point of each set of MSS 
samples (less than 10% of the maximum signal) was subtracted as background from the corresponding MSS fractions to obtain the 
values shown. 
Results 
Review of In Vitro Reaction 
Protein transport from the ER was reconstituted in perfo- 
rated yeast spheroplasts  using  35S-radiolabeled ppaf as  a 
marker secretory protein (Baker et. al., 1988). ppaf is post- 
translationally translocated into the lumen of the ER during 
a 15-min incubation at 10°C (stage I). Once in the ER lumen, 
pro-a-factor  (paf)  is  glycosylated  with  three  N-linked 
core-carbohydrate chains  which  are  then processed by a 
mannosidase and two glucosidases in the ER (Esmon et al., 
1981; Abeijon and Hirschberg, 1992; Latterich and Schek- 
man, 1994). After the membranes are washed to remove un- 
translocated precursor, the perforated cells are incubated at 
20-29°C with a cytosol fraction, an ATP regenerating sys- 
tem, and GDP-mannose (stage II). During this stage, core- 
glycosylated pro-a-factor (core-gpaf) is transported to the 
Golgi apparatus where it is further glycosylated with "outer- 
chain" mannose residues in al->6 linkage. All glycosylated 
forms of gpaf bind to the plant lectin Con A  whereas all 
outer chain-modified forms of gpa,  f bind to antibodies spe- 
cific to al->6 linkages (Franzusoff and Schekman,  1989). 
Transport efficiency is expressed as the ratio of radiolabeled 
gl~f precipitated with outer chain antibodies to total gpaf 
precipitated with Con A. 
Accumulation  of Functional ER-derived 
Transport Vesicles 
We previously showed that anti-Yptlp F,b antibody fragments 
block ER  to  Golgi protein  transport  in  perforated yeast 
spheroplasts and prevent the attachment of  ER-derived trans- 
port vesicles to Golgi membranes. The Yptlp-specific block 
caused the accumulation of functional transport vesicles that 
were physically separable from ER and Golgi membranes 
(Rexach and Schekman, 1991). To obtain sufficient amounts 
of vesicles for purification, we needed to conduct large scale 
in vitro incubations.  Large amounts of antibody F,b frag- 
ments  were  required  for  repeated  vesicle  preparations. 
Therefore a mutation in the Yptl protein was used as an alter- 
nate inhibitor of Yptlp function. A strain that carries a mu- 
tant form of  the Yptl protein (Schmitt et al., 1988) was exam- 
ined for the ability to accumulate transport vesicles during 
in vitro incubations. The yptl ts strain that we used for all 
experiments (referred to as yptl ts throughout the text) car- 
ries an independent mutation in the glucosidase 1 gene (glsl- 
1) which renders the ER unable to trim terminal glucose 
residues from N-linked core-carbohydrate chains (Esmon et 
al., 1984). A mutation in the GLS1 gene has no effect on cell 
growth, protein secretion, or outer chain modification (Es- 
mort et al.,  1984; Tsai et al.,  1984), and was necessary to 
test  whether  diffusible  ER-derived transport  vesicles  are 
competent for fusion with ER, as well as with Golgi mem- 
branes (see below). 
Perforated cell and cytosol extracts were prepared from 
yptl ts and wild-type strains, and tested for the ability to sup- 
port ER to Golgi protein transport in the presence of ATP 
at physiologic temperature, yptl  ts  extracts were  10 times 
less  efficient than  wild-type  in  reconstituted transport  at 
25°C (Fig.  1 A). To determine the stage of transport that is 
blocked in yptl ts reactions, we examined the efficiency of 
vesicle budding  and  vesicle fusion.  Vesicle budding  was 
measured by quantifying the release of membrane-enclosed 
core-gpaf from perforated cells, and vesicle fusion was mea- 
sured by quantifying the subsequent appearance of Golgi- 
modified  forms  of gpaf (Rexach  and  Schekman,  1991). 
Wild-type and yptl ts cells had equivalent vesicle budding 
efficiencies (Fig. 1 B, left), but vesicle fusion was 10 times 
less efficient in the yptl ts (Fig. 1 B, right). Thus, yptl ts per- 
forated cells produce transport vesicles, but fail to consume 
them. 
Quantitative western blot analysis was used to measure the 
accessibility of ER-resident proteins to transport vesicles. 
After 35 min of vesicle budding, more than 35 % of core- 
gpaf was incorporated into vesicles, compared to less than 
5 % of Kar2p (Fig. 2, left). Kar2p is a lumenal ER-resident 
protein,  whereas  core-gpaf  is  a  soluble  secretory  pro- 
protein (Rose et al.,  1989; Julius et al.,  1984).  Likewise, 
25%  of Betlp and  15%  of Sec22p were incorporated into 
vesicles, compared to less than 2 % of Sec61p (Fig. 2, right). 
Sec22 and Betl proteins are embedded in the ER membrane 
(Newman et al.,  1992; Ossig, R., unpublished results) and 
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Figure 2.  ER-resident proteins  are sorted prior to the release of 
transport vesicles. Stage II reactions containing yptl ts perforated 
cells and cytosol were incubated at 25°C for the indicated times, 
or at 0*C for the zero time point control. Chilled samples were frac- 
tionated in a microcentrifuge,  and MSS fractions were taken from 
the meniscus. One set of MSS fractions (le~) was treated with tryp- 
sin and trypsin inhibitor, and heated at 95*C in Ix Laemmli sample 
buffer. Half  of the sample was analyzed for its content of gtuxf  using 
precipitation with Con A as described in the Methods for stage II 
transport,  and the other half was heated  in  Ix Laemmli sample 
buffer with 2 % /%ME,  subjected to SDS-PAGE, immunoblotted 
with  anti-Kar2p  antibodies  (1:5,000) followed by ~zSI-protein  A, 
and the radioactivity  was quantified using standard  software in a 
Molecular Dynamics Phosphorlmager.  A second set of MSS frac- 
tions (righO was heated at 65°C  in Ix Laemmli buffer with 2% 
B-ME,  subjected  to SDS-PAGE, and  immunoblotted  with  anti- 
Sec61p (1:5,000), anti-Sec22p (1:5,000), and anti-Betlp (1:500) an- 
tibodies  fotlowed by t2~I-protein A, and  quantitation  in a Phos- 
phorlmager.  The zero time point of each set of MSS samples was 
subtracted as background from the corresponding MSS fractions to 
obtain the values shown. Values shown in the right panel are the 
average of two  separate  experiments.  An aliquot  of an unfrac- 
tionated reaction, referred to as "total," served to calculate the per- 
cent of each protein  released from perforated  cells. 
are components of ER-derived transport vesicles (see be- 
low),  whereas  See61  is  a  resident  ER membrane protein 
(Stifling  et  al.,  1992;  Stifling,  C.,  unpublished  results). 
Based on these results, we concluded that sorting of proteins 
in the ER must occur prior to the scission of diffusible ER- 
derived transport vesicles. 
We examined whether ER-derived vesicles that diffuse out 
of perforated ceils during in vitro incubations were attached 
or not to Golgi membranes because Golgi membranes are 
also released from perforated cells during in vitro incuba- 
tions. Vesicle targeting is measured by quantifying the per- 
centage of core-gpaf in  the  MSS  fraction that  sediments 
slowly (within vesicles) or rapidly (with Golgi membranes) 
in velocity sedimentation gradients (Rexach and Schekman, 
1991).  Vesicles  are  marked by their  content  of 3sS-core- 
gpa,  f, whereas Golgi membranes are marked by their content 
of GDPase activity (Yanagisawa et al., 1990), and content of 
outer-chain-modified gpo~f (Rexach and Schekman,  1991). 
Membranes released from wild type and yptl ts perforated 
cells  after  35  rain  at  25°C  were  subjected  to  velocity 
sedimentation in Ficoll gradients (Fig. 3). In wild type reac- 
tions,  all of the gpcrf accumulated within membranes that 
sedimented fast, together with the majority of Golgi mem- 
branes  (Fig.  3,  top);  half  of  the  gpo~f was  outer-chain 
4 
8 
2 
0.2 
0.1 
4 
•  o  ,~  o 
5  10  15 
top 
0.08 
0.04 
2O 
bottom 
fraction 
Figure 3. Transport vesicles that accumulate in yptl ts reactions are 
separable  from Golgi membranes in F/s  gradients.  A  scaled-up 
MSS fraction (300 ~1) obtained from a wild-type (Sec  +) or yptl ts 
Stage II reaction was loaded in a F/s gradient (prepared as described 
in Materials and Methods) and subjected to centrifugation for 2 h 
at 100,000 g.  18 fractions were collected from the top. The gpaf 
content,  GDPase activity, and the density  of every fraction  was 
quantified as described in Materials and Methods.  Closed circles 
represent  core-gpcff.  Closed  triangles  represent  outer-chain 
modified gpcff. Open circles  represent  GDPase activity. Crosses 
represent  the  density  of each  fraction  expressed  in  %  sucrose 
(wt/wt). 
modified,  and  the  other  half remained core-glycosylated, 
possibly  due  to  inefficient  vesicle  fusion  or  outer-chain 
glycosylation. Slowly-sedimenting membranes that contain 
GDPase activity may represent Golgi-derived transport vesi- 
cles.  In yptl  ts  reactions,  all  of the gpocf remained core- 
glycosylated and accumulated within membranes that sedi- 
mented slowly, whereas the majority of Golgi membranes 
sedimented rapidly (Fig. 3, bottom). Thus, ER-derived vesi- 
cles are physically separable from large Golgi membranes 
that contain  GDPase activity and accumulate outer chain 
gpotf.  Small  GDPase-containing  vesicles  were  separated 
from ER-derived transport vesicles by velocity flotation in 
sucrose gradients (see Fig.  9 below). 
Purification of ER-derived Transport Vesicles 
Transport vesicles that accumulate in ypt/ts extracts were 
purified using differential centrifugation and a combination 
of velocity and equilibrium density gradients.  A  flow dia- 
gram of the purification is shown in Fig. 4. A large mix of 
yptl  ts perforated cells,  cytosol, and an ATP regeneration 
system was incubated for 30 min at 25°C to generate ER- 
derived transport vesicles that contained 3sS-core-gtxff (see 
Materials and Methods). The chilled reaction mix was sub- 
jected to centrifugation at medium speed to remove perfo- 
rated cells and the majority of  cellular membranes. The MSS 
contained slowly sedimenting vesicles, and fragments of cel- 
lular membranes (see Table H below). Vesicles were concen- 
trated by sedimentation onto a  step  sucrose gradient  (re- 
ferred to as VS I) and equilibrated as a single sharp peak at 
a density equivalent to 30% sucrose (wt/wt)(1.13g/ml) (Fig. 
5, top). The peak of vesicles (28-32 % sucrose) was pooled 
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vesicles. 
(pool  1),  the  concentration  of  sucrose  adjusted  to  15% 
(Wt/wt)  by dilution,  and  the  sample subjected to  velocity 
sedimentation in a  F/s gradient (referred to as VS 1I) that 
resolves membranes on the basis of size. Vesicles sedimented 
slowly as a single peak without reaching equilibrium density 
(Fig. 5, middle).  The peak of vesicles was pooled (pool 2), 
the sample density was adjusted to 35 % Nycodenz (wt/vol), 
and vesicles were floated to equilibrium in a Nycodenz den- 
sity gradient  (referred to  as EQ) to remove all remaining 
soluble proteins and particles.  The vesicles equilibrated as 
a single peak at a density of 1.12 g/ml (Fig. 5, bottom),  and 
were pooled (pool 3). 
To assess the purity of ER-derived transport vesicles, we 
measured the fold enrichment of transport vesicles and the 
recovery of cellular  markers  at  each purification  step.  A 
purification chart is presented in Table I. Fold enrichment 
was determined by calculating the ratio ofprotease-protected 
core-gpoE to total micrograms of protein in each fraction. 
The  value obtained for the  total  fraction was adjusted  to 
reflect core-gpotf within vesicles, because a significant por- 
tion  (Fig.  60%)  of the  core-gpa,  f  in  this  fraction resided 
within ER membranes. We calculated that ER-derived trans- 
port vesicles were enriched 900-fold from the initial mix of 
perforated  cells  and  cytosol.  Quantitative  ~2~I-protein A 
Western blot analysis was used to determine the percent re- 
covery of protein markers of cellular membranes and cytosol 
(Table ID. The MSS contained slowly sedimenting vesicles, 
Golgi membranes, and detectable amounts of plasma mem- 
brane,  vacuole,  and  mitochondrial  markers.  These  con- 
taminants were largely separated from ER-derived vesicles 
after isopycnic centrifugation in a sucrose gradient (Table II, 
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Figure 5. Purification of ER-derived transport vesicles. A large mix 
of ypt/ ts-perforated  cells,  membrane-free  cytosol,  and an ATP 
regeneration  system was incubated for 30 min at 25°C,  and then 
chilled (see Materials and Methods, and Fig. 4 for a flow diagram). 
Perforated  cells were sedimented  at  12,000 g for 2 rain and the 
resulting MSS was loaded on top of a sucrose step gradient (VS I). 
Membranes were sedimented for 16 h at 80,000 g, and equilibrated 
at isopycnic densities.  The peak of fractions that contained trans- 
port vesicles were detected by their content of  radioactive core-gpaf 
and were pooled (pool 1 ). The sample density was adjusted to 15 % 
sucrose (wt/w0, loaded in a F/s gradient (VS II), and centrifuged 
at 100,000 g for 2 h. The vesicle peak was pooled as before (pool 
2). The sample density was adjusted to 35% Nycodenz, loaded in 
the bottom of a  Nycodenz  step gradient  (EQ), and  membranes 
floated to equilibrium during overnight centrifugation at 180,000 g. 
The vesicle peak was pooled  as before  (pool  3),  and analyzed. 
Closed circles represent radiolabeled forms of ct factor in the top 
and middle panels, and core-gpaf  in the bottom panel. Crosses rep- 
resent solution density in grams per milliliter (g/ml). Smooth lines 
and open circles represent protein concentration. The arrows in the 
top x-axis point to the direction  of membrane movement during 
sedimentation, and the arrow base marks the interface between load 
and gradient material. 
VS 1).  Although  detectable amounts of Golgi and vacuole 
membranes persisted throughout the purification, more than 
99.5 % of these membranes were removed (Table II, Pool 3). 
ER-derived Transport Vesicles Fuse with cis-Golgi, 
but not with ER Membranes 
The fusion competence of transport vesicles that accumulate 
in vitro was examined using assays that detected vesicle fu- 
sion to cis-Golgi,  or to ER membranes. Because we used 
a  glucosidase I-deficient yptlts  strain,  the  transport vesi- 
cles that accumulate in  vitro contain the  32-ki)  "glucose- 
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Core-glycosylated 
Fraction  Volume  Protein  35S-pro-c~-factor  Specific units  Enrichment  Recovery 
ml  lxg  cpm  x  10  -5  cpm  x  10-2/1~g  (-fold)  % 
Total  13  54,000  220/70  4.1 / 1.3  100 
MSS  12  39,000  66  1.7  1.3  96 
Pool  1  0.9  670  31  46  35  46 
Pool  2  1.2  73  13  180  140  25 
Pool  3  0.8  3.4  4.2  1,200  950  11 
The content of protein and protease-protected gpoff (pp-gpotf) was determined for each purification step. The protein concentration in aliquots from each pool was 
determined using an amido-black protein detection assay (see Materials and Methods), and the content of protease protected 3sS-gpotf was determined by treating 
aliquots with trypsin, then trypsin inhibitor, followed by precipitation  with Con A-Sepharose and quantitation in a scintillation  counter, as for stage 1I transport 
reactions (see Materials and Methods). Two values are given for "core-glycosylated 35S-pro-c~-factor"  and "specific units" in the total fraction: one indicates the 
total core-gl~f in the fraction (left value), and the other was adjusted to reflect  the core-gpcxf within diffusible vesicles (right value) and was deduced from the 
efficiency of vesicle budding (see "Vesicle budding and fusion assay" in Materials and Methods). Fold enrichment was calculated with respect to protease-protected 
core-gpcff within diffusible vesicles in the Total fraction. The values given for "percent recovery" were adjusted to account for sample aliquots taken throughout 
the purification.  All values were rounded off to two significant figures after calculations were performed. 
untrimmed" form of core-glycosylated  pro-oe-factor (referred 
to as gls-core-gpoff and core-gpcff throughout the text) in- 
stead of the 29-kD wild-type form. Altogether, nine glucose 
residues  are  trimmed  from three  N-linked  carbohydrate 
chains to convert gls-core-gpcff to the wild-type form; a ter- 
minal glucose residue is removed by glucosidase I, and two 
more are removed by glucosidase II after the terminal glu- 
cose has been removed (Roth et al.,  1990).  The glsl-1 and 
wild type forms of core-gpcffare shown in Fig. 6 A, for refer- 
ence. Fusion of  ER-derived transport vesicles with wild-type 
ER membranes was measured by quantifying the percent 
glucose-trimming of radiolabeled gls-core-gpotf by glucosi- 
dase I and II in the ER lumen (see Latterich and Schekman, 
1994), whereas fusion of vesicles with cis-Golgi membranes 
was measured by quantifying the conversion of radiolabeled 
gls-core-gpoLf  to "outer-chain" modified forms by of,6 man- 
nosyl-transferases in the cis-Golgi lumen (see review of in 
vitro assay; Rexach and Schekman, 1991). A sample homo- 
typic ER-membrane fusion experiment is presented in Fig. 
6 B, for comparison. Washed glsl-1 ER membranes that con- 
tained radiolabeled g/s-core-gpaf were incubated with fresh 
wild-type ER membranes in the presence of various addi- 
tions, and completed fusion reactions (except for reactions 
that contained Triton X-100) were treated with trypsin and 
then trypsin inhibitor to quantify membrane-enclosed gpcrf 
(Fig. 6 B, lanes 1-3).  ER-membrane fusion reached 21% 
efficiency at physiological temperature in the presence (Fig. 
6 B, lane 2) but not in the absence (Fig. 6 B, lane 1 ) of an 
ATP regeneration system, as judged by percent glucose trim- 
ming. Addition of cytosol neither stimulated nor inhibited 
ER-membrane fusion (not shown). When membrane bar- 
riers were removed by the presence of 1% Triton X-100 in 
the reaction, 92 % of the g/s-core-gpoff was trimmed (Fig. 6 
B, lane 3). A smear rather than a sharp band at 29 kD results 
from the addition of TX-100, which interferes with glucosi- 
dase activity. The smear may represent the nine intermediates 
in the conversion of core-gpotf from the g/s to the wild-type 
form, and did not result from proteolysis of gls-core-gpotf, 
because a  single species of deglycosylated proaaCactor was 
formed when samples were treated with endo H (not shown). 
ER-derived transport vesicles did not fuse with ER mem- 
branes. Glucose trimming was not detected when aliquots of 
isolated vesicles (from pool 1) were incubated at physiologi- 
cal temperature with an ATP-regeneration system and wild- 
type microsomes that contained fusion-competent ER mem- 
branes (Fig. 6 C, lanes 2 and 23. These conditions normally 
Table IL Recovery of Cellular Markers 
Pool  1 
Marker protein  Cellular location  Total  MSS  (Percent recovery)  Pool 2  Pool 3 
core-gl~f  lum  ERV  100  96  46  25  11 
Sec61p  tm  ER  100  7  0  0  0 
GDPase  tm  Golgi  100  37  3.4  1.2  0.4 
VPM1  tm  Vac  100  29  2.9  0.7  0.1 
PM ATPase  tm  PM  100  17  0  0  0 
F1Bo  pm  Mito  100  28  0  0  0 
PGK  sol  Cyt  100  88  0.3  0  0 
Aliquots of Total and MSS fractions that contained 31.25, 6.25, and 1.25 micrograms of protein, and aliquots of pools 1, 2, and 3 fractions that contained 1.25, 
0.25, and 0.05 ~g of protein, respectively, were subjected to SDS-PAGE, and immunoblotted with anti-Sec61p (1:5,000), anti-PGK (1:10,000), anti-PM ATPase 
(1:1,000), anti-VPM 1 (1:500), and anti-FIBo (1:1,000) antibodies. Immune-complexes  were detected by ~2SI-protein A and quantified in a Phosphorlmager; the 
values obtained were expressed as disintegrations per/~1 of sample analyzed, and were used to calculate the % recovery of each marker after each purification 
step. In the case of core-gpt~f,  values were calculated as in Table I. Values obtained in GDPase assays (see Materials and Methods), were expressed as units of 
enzyme activity per ~,1 of sample analyzed, and were used to calculate % recovery. Core-gl~f is a lumenal (/urn) marker of ER-derived transport vesicles (ERV); 
Sec61p is a transmembrane (TM) protein that marks the endoplasmic reticulum (ER); guanosine diphosphatase (GDPase) marks the Golgi complex (Golgi);  an 
integral membrane component of the vacuolar proton pump (VPM1)  marks the yeast vacuole (Vac);  plasma membrane ATPase (PM ATPase) marks the plasma 
membrane (PM); a subunit of the mitochondrial proton pump (F1Bo) is a peripheral membrane (prn) protein that associates tightly with the mitochondrial membrane 
(MiO; phosphoglycerolkinase (PGK) is a soluble (sol)  protein in the cytosol (Cyt). 
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Figure 6. Fusion competence of ER-derived transport vesicles. (A) Phosphor-image displaying  g/s-core-gp~f  and wild-type core-gpaf. Ra- 
diolabeled  ppcd was transloeated at low temperature into microsomes prepared from glsl-1 or wild-type  yeast, as indicated. Chilled micro- 
somes were washed, treated with trypsin and trypsin inhibitor, mixed with 2x  Laemmli sample buffer with 2% B-ME, heated to 95°C, 
and resolved in a  12.5%  SDS-PAGE. The gel was fixed, dried, exposed to a phosphor plate, and visualized in a Molecular Dynamics 
PhosphorImager. (B) Control reactions to test the fusion-competence of ER membranes. Washed glsl-1 microsomes (75 #g) that contained 
radiolabeled  gls-core:gpotf (prepared as in A) were mixed with microsomes (75 #g) prepared from wild-type (lane 1-3), and with an ATP 
regeneration system (lane 2) or 1% Triton X-100 (lane 3) in a total volume of 50 gl. Reactions were incubated for 60 min at 30°C. Chilled 
reactions were treated with trypsin, and then trypsin inhibitor, and processed as in A.  The percent trimming (conversion of the 32-kD 
gls-core-gpaf to the 29-kD wild-type form) was quantified using standard software in a Molecular Dynamics PhosphorImager. (C) Fusion 
competence of isolated transport vesicles. Aliquots (5/~1) of an enriched transport vesicle preparation (from pool 1 ) were mixed with 25 
#g of wild-type yeast microsomes, an ATP regeneration system, and 100 t'g of cytosol (unless otherwise indicated) in the presence (lanes 
1-4) or absence (lanes 1'-4') of GDP-mannose. The reactions in lanes 2 and 2' did not contain eytosol. Reactions were incubated for 1 h 
at 0°C (lanes 1 and 1') or 20°C (lanes 2-3 and 2'-3'). Chilled reactions were treated with trypsin and trypsin inhibitor, and processed as 
in A. The percent trimming was quantified as before, and the percent transport was quantified using precipitation  with Con A and anti-outer- 
chain antibodies as described in the Methods for stage II transport. (D) Fusion competence of  purified transport vesicles. Aliquots of  purified 
transport vesicles (from pool 3) were mixed or not with fresh eytosol and perforated spheroplasts prepared from wild-type cells, and an 
ATP regeneration mix, to the same concentrations as for stage II transport. To the tubes containing no ATE we added apyrase (0.5  U) 
to hydrolyze residual ATP; these tubes were supplemented with 50 #M GDP-mannose, normally added in the ATP regeneration mix. Sam- 
pies were incubated for 1 h at 0 ° or 20°C, and reactions terminated by the addition of 2 % SDS and heated to 95°C. Samples were processed 
for precipitation with Con A and anti-outer chain antibodies as described in the Materials and Methods for stage II transport. 
Figure Z Morphology of ER-derived transport vesicle examined under the electron microscope. A and B show purified vesicles from pool 
3 that were attached to an ionized support grid, fixed, and visualized by negative stain with 2% uranyl acetate. C and D show vesicles 
from the same pool 3 that were sedimented onto a hardened agarose ~bed" and processed for thin section electron microscopy. Magnifica- 
tions were 25,000x  in A, 57,000x  B, 34,000x  C, and 57,000x  D.  Bars, 200 nm. 
Rexach et al. Endoplasmic Reticulum-derived Transport Vesicles  114t Figure 8. Polypeptide composition of ER-derived transport vesicles. (A) Protein from each fraction of the Nycodenz equilibrium gradient 
(EQ) was concentrated by precipitation with trichloroacetic acid in the presence of deoxycholate, resolved in a 10-15 % acrylamide gradient 
gel, and stained with silver (see Materials and Methods). (B) Aliquots of pool 3 were diluted 10-fold in tubes with the indicated solutions 
0388 is 20 mM Hepes, pH 6.8, 150 mM KOAc, 250 mM sorbitol, 5 mM MgOAc). A 1% Triton X-100 solution was used. Sodium carbonate 
was dissolved in water. After 10 min at room temperature, vesicles were sedimented at 100,000 g for 45 min. The pellets were resuspended 
in Laemmli sample buffer with 2%/~-ME, and the proteins resolved by SDS-PAGE and visualized by silver stain. Arrows indicate the 
most abundant vesicle proteins, and some were assigned apparent molecular mass.  ERVp is an abbreviation for ER-derived transport 
Vesicle protein. 
support efficient ER-membrane fusion (Fig. 6 B, lane 2). Ad- 
dition of cytosol did not stimulate "back-fusion" (Fig. 6  C, 
lanes 3  and 3').  Glucosidase activity was present in mem- 
branes because 40 % of the g/s-core-gpotf was trimmed when 
membrane barriers were removed by the presence of 1% Tri- 
ton X-100 (Fig.  6  C,  lanes 4  and 4'). 
Transport vesicles were active  for  fusion with cis-Golgi 
membranes.  Completion of protein transport was  detected 
when aliquots of isolated vesicles (from pool 1) were mixed 
with cytosol,  an ATP-regeneration system,  GDP-mannose, 
and wild-type microsomes that contained fusion-competent 
cis-Golgi  membranes (Fig.  6  C).  Vesicle  fusion with cis- 
Golgi membranes was not detected at 0°C (Fig. 6 C, lane 1 ), 
but reached 24%  efficiency at 20°C (Fig. 6  C, lane 3) in a 
Table III. Fold Enrichment of Transport Proteins 
Pool 1 
Protein  Cellular location  Total  MSS  (fold enrichment)  Pool 2  Pool 3 
core gpotf  lum ER/ERV  1  0.49/1.3  24/62  48/130  3201840 
Seel3p  pm  cyt  1  0.88  0.62  0  0 
Secl7p  pm  cyt  1  0.87  0.99  2.7  0 
See21  pin  cyt  1  1.4  2.7  2.5  0 
See22p  tm  ER/ERV  1  0.23/1.3  3.7/21  9.4/53  81/450 
Sec23p  pm  cyt  1  4.5  2.8  0  0 
Arfl,2p  pm  eyt/Golgi  1  1.2  0  0  0 
Sarlp  pm  cyt/ER  1  0.26  0  0  0 
Yptlp ts  pm  cyt/Golgi  1  0.95  0.68  0  0 
Betlp  tm  ER/ERV  1  0.62/1.3  4.7/10  13/28  210/450 
Slylp  pm  cyt  1  0.67  5.4  0  0 
or-COP  pm  cyt  1  1.6  12  13  10 
/~//3'/3,-COP  pm  cyt  1  1.7  5.0  6.1  5.9 
~-COP  pm  cyt  1  1.7  8.2  6.7  3.5 
Aliquots of total and MSS fractions that contained 31.25, 6.25, and 1.25/~g of protein, and aliquots of pools 1, 2, and 3 fractions that contained 1.25, 0.25, 
and 0.05/~g of protein, respectively, were subjected  to SDS-PAGE  and immunoblotted  with anti-Sec  13p (1:1,000), anti-Secl7p (1:2,000), anti-Sec2  l p (1:1,000), 
anti-Sec22p (1:5,000), anti-Sec23p  (1:1,000), anti-Arfp (1:1,000), anti-Sarlp (1:1,000), anti-Yptl  p (1:2,000), anti-Betlp (1:500), anti-Sly  1  p (1:1,000), and anti- 
coatomer (1:5,000) antibodies. Immune-complexes  were detected by I~sI-protein  A and quantified  in a Phosphorlmager; the values obtained were expressed as 
disintegrations  per ~,g of protein analyzed, and served to calculate  the values shown. Fold enrichment  was calculated  with respect to the amount of each marker 
in the total fraction, which was normalized  to a value of I. The values presented for core-gp~f were obtained  by PhosphorImager  quantitation  of triply glycosylated 
3SS-core-gpaf  in nitrocellulose filters; these values include core-gpcff  that is not protease protected. Two values for fold enrichment are given for proteins that 
are highly enriched in transport vesicles: the value on the leR indicates the fold enrichment with respect to the amount of marker in the total fraction, and the 
value on the right indicates fold enrichment calculated with respect to the amount of marker within diffusible  vesicles in the total fraction. 
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Figure 9.  ER-derived transport vesicles are physically separable 
from Golgi-derived vesicles. Membranes that sediment slowly in 
velocity sedimentation gradients (Fig. 3, bottom, lanes 6-12) were 
pooled and the  solution density was  adjusted to  50%  sucrose 
(wt/vol). The sample was loaded in the bottom of a 5 ml Beckman 
Ultraclear tube, and aliquots of 45, 40, 35, and 30% sucrose were 
layered on top, all dissolved in B88. Membranes floated towards 
equilibrium during 20 h of centrifugation at 180,000 g. Isopycnic 
equilibration  required  more  than  32  h  of centrifugation (not 
shown). Aliquots were analyzed for their content of radiolabeled 
,-factor, GDPase activity, and density as described in the Materials 
and Methods. 
reaction that required cytosolic protein (Fig. 6 C, compare 
lanes 2 and 3) and the presence of intact membranes (Fig. 
6  C,  compare lanes 3  and 4).  The heterogeneous smear 
above  the  32-kD  g/s-core-glxff band  represented  outer 
chain-modified glmf, and its formation required the pres- 
ence of GDP-mannose in the reaction (Fig. 6  C, compare 
lanes 3 and 33. Purified transport vesicles remained active 
for fusion with cis-Golgi membranes. Completion of protein 
transport  was detected when aliquots of purified vesicles 
(pool 3) were mixed with fresh perforated cells and cytosol 
prepared from a wild-type strain (Fig. 6 D). Transport re- 
quired the addition of Golgi membranes and ATP, and was 
stimulated by cytosol. Transport was not detected at 0°C, but 
reached 22 % efficiency at 20°C. The efficiency of transport 
from purified vesicles was comparable to the initial effi- 
ciency of transport from vesicles in the MSS fraction (not 
shown) and Pool 1 (Fig. 6  C, lane 3). 
Morphology of  ER-derived 
Transport Vesicles 
Fig. 7 shows typical electron micrographs of transport vesi- 
cles visualized by negative stain (,4 and B) and thin-section 
microscopy (C and D). Purified vesicles in pool 3 were at- 
tached to ionized support grids, fixed, and stained with ura- 
nyl acetate; pool 3 contained a uniform population of vesi- 
cles  that collapsed during  dehydration, indicative of the 
absence of a rigid structural coat (Fig. 7, A and B). Vesicles 
from the same pool 3  were  sedimented onto a  hardened 
agarose "bed; fixed, and processed for thin-section electron 
microscopy. An agarose "bed" was used because vesicle pel- 
lets were otherwise invisible. The vesicles were ~60 nm in 
diameter,  lacked  apparent  protein  coats  surrounding  the 
membrane, and were aggregated as a result of sedimentation 
(Fig. 7,  C and D). 
Molecular Composition of  ER-derived 
Transport Vesicles 
The protein composition of purified vesicle fractions was 
analyzed by SDS-PAGE,  and visualized by silver stain. Pro- 
teins in aliquots of fractions from the last gradient (EQ) were 
concentrated by precipitation with trichloroacetic acid in the 
presence of deoxycholate, resolved in a  10 to  15 % acryl- 
amide-SDS gradient gel, and stained with silver (Fig. 8 A). 
The protein composition of fractions that contained trans- 
port  vesicles  was  highly  simplified (fractions  7-9),  and 
clearly distinct from the load (fractions 13-16) and fractions 
from all previous purification steps (not shown; see MSS in 
Fig. 10, lane 1 ). The 68/55-kD protein doublet in fractions 
3, 8, 9, and 10 was human keratin introduced by sample han- 
dling. The most abundant vesicle proteins were assigned an 
apparent molecular mass and were named "ERV" proteins, 
an abbreviation for E__R_R-derived transport vesicle proteins. 
ERV proteins were tightly associated with the vesicle mem- 
brane  and  resisted  extraction  with  1M  KOAc  or  0.2  M 
Na~CO3 at pH  11, but not with 1% TX-100  (Fig. 8 B). 
The enrichment or depletion of various proteins that func- 
tion in ER to Golgi protein transport in vivo was determined 
for each purification step using quantitative l~I-protein A 
Western blot analysis (Table Ill). Secl3, Sec23, and Sarl pro- 
teins were resolved early in the purification; these are pe- 
ripheral membrane proteins that function to drive vesicle 
budding from ER membranes (Salama et al., 1993) and can 
form a coat around ER-derived transport vesicles (Barlowe 
et al., 1994).  In contrast, Betl and Sec22 proteins were en- 
riched 450-fold;  these  are  membrane-embedded proteins 
with structural similarity to synaptobrevin (Dascher et al., 
1991).  Boslp was enriched to the same extent as Sec22p, 
judged by ECL-Western blot analysis (not shown). Sec22 and 
Bosl proteins function in transport vesicle docking or fusion 
with Golgi membranes (Kaiser and Schekman, 1990;  Shim 
et al.,  1991; Lian and Ferro-Novick,  1993).  Subunits of 
yeast coatomer were also detected in purified vesicle frac- 
tions and were slightly enriched. We calculated that coat- 
omer constituted only 1% of the vesicle protein by compari- 
son to known amounts of purified coatomer (Hosobuchi et 
al.,  1992) in  1z'I-Western blots (not shown).  Arf proteins 
were absent in purified vesicle fractions; these proteins func- 
tion in the recruitment of coatomer and clathrin to mem- 
branes (Palmer et al., 1993; Stamnes and Rothman, 1993). 
Although Yptlp is suspected of  binding ER-derived transport 
vesicles (Segev,  1991; Lian and Ferro-Novick,  1993),  the 
mutant form of Yptlp used in this study was not detected in 
vesicles, perhaps due to its inability to bind GTP (Wagner 
et al.,  1987).  Finally, neither Secl7 nor Slyl proteins were 
detected in purified vesicle fractions. Secl7p/otSNAP is a pe- 
ripheral membrane protein that functions in transport vesicle 
docking or fusion (Kaiser and Schekman, 1990; Clary et al., 
1990; Griffet al., 1992) and Slylp is a peripheral membrane 
protein  that  when  mutated  can  replace  Yptlp  function 
(Dascher et al.,  1991). 
Because purified vesicle fractions contained detectable 
amounts of Betlp,  Sec22p,  Boslp, coatomer, and GDPase 
(see Tables II and liD, we applied other techniques to deter- 
mine whether these proteins were components of the same 
vesicles.  Small Golgi vesicles that contained GDPase co- 
fractionated with ER-derived transport vesicles in velocity 
sedimentation (Fig.  2)  and equilibrium density gradients 
(not shown), but were separated by velocity flotation in su- 
crose gradients (Fig. 9). GDPase-containing vesicles floated 
towards equilibrium at a slower rate than ER-derived trans- 
Rexach et al. Endoplasmic Reticulum-derived Transport Vesicles  1143 Figure 10.  Com-gpa~f, Betlp, Sec22p, Boslp, and coatomer reside in the same vesicles. Vesicles in MSS fractions  from yptl ts stage II 
incubations were immunoadsorbed onto protein A-Sepharose beads using anti-Betlp IgG (lanes 2-4, A-C) or anti-Sec22p affinity-purified 
antibodies (lane 5, A-C). Immunoadsorbtions  were conducted for 2 h in the absence of competitor peptides (lanes 2 and 5, A-C) or in 
the presence of the RTQLFG competitor peptide (lane 3, A-C) or the Betl immune-peptide (lane 4, A-C). At the end of the incubations 
the beads were sedimented, the supernatants were saved, and beads were washed repeatedly in preparation for detergent extractions. (A) 
Top insert.  Immunoisolates and supernatant  fractions  (unbound) were treated with trypsin and then trypsin inhibitor, and processed for 
Con A precipitation as described in stage II transport in the Materials and Methods. Immunoadsorbtion  of ER-derived transport vesicles 
to Sepharose beads is expressed as the per cent of the ratio of protease protected  core-gp~f (pp-core-gpctf) in immunoisolates divided 
by the summation of pp-core-gpaf in the supernatant  and immunoisolate fractions.  (A) Gel. Vesicle proteins were extracted from beads 
with  1% Triton X-100 in B88, resolved by SDS-PAGE, and visualized by silver stain (lanes 2-5,  panel A). A diluted aliquot of a MSS 
fraction was loaded in lane 1 of the same gel for comparison;  it is underexposed in relation to lanes 2-5. An aliquot of gradient-purified 
vesicles (from pool 3) was loaded in lane 6 of the same gel, for comparison;  it is overexposed in relation to lanes 2-5.  (B) Vesicle proteins 
were extracted from beads with  1% Triton X-100 in B88, resolved by SDS-PAGE, and visualized by Phosphorimaging of ~:5I-protein A 
Western blots using anti-Betlp  (1:500), anti-Sec22p  (1:5,000), anti-Boslp  (1:2,000), and anti-coatomer  (1:5,000) antibodies.  Gradient- 
purified vesicles from pool 3 (0.3 mg) were diluted fivefold in B88, sedimented to a pellet at 100,000 g for 45 min, resuspended in sample 
buffer, and loaded in lane 1. gls-core gpcd is visible because it is labeled with [35S]methionine. (C) After extracting vesicle proteins from 
beads with 1% Triton X-100 dissolved in B88, beads were washed twice more with the same buffer, and the remaining proteins extracted 
with lx Laemmli sample buffer with 2%/3-ME at 70°C for 15 min. SDS extracts were analyzed by SDS-PAGE, and visualized by Phos- 
phorimaging of western blots using anti-Betl  (lanes 2-4) or anti-Sec22 antibodies (lane 5) at the same dilution as in B. Heavy chain IgG 
is visible because it binds  ~25I-protein  A. Contiguous panels are from the same gel. Each panel was blotted separately with an antibody, 
or antibody mix in the case of Sec22 and Boslp, at the same dilution as in B. 
port vesicles. Because the protein composition of GDPase- 
containing membranes could not be detected by silver stain 
(not shown),  we believe that these membranes represent a 
small contaminant in purified vesicle preparations. 
Antibodies that recognize Betlp or Sec22p were used to 
adsorb vesicles from MSS fractions onto protein A-coated 
Sepharose  beads,  and  the  presence  of core  gpcd,  Betlp, 
Sec22p, Boslp, and coatomer on immunoisolates was exam- 
ined  by  Western  blot  analysis  (Fig.  10).  Vesicles  were 
marked by their content of protease-protected, radiolabeled 
g/s-core-gpaf. An IgG fraction of antibodies prepared against 
the  NH2  terminus  of Betlp  (see  Materials  and  Methods) 
efficiently adsorbed 80% of ER-derived transport vesicles to 
Sepharose beads (Fig.  10 A top insert,  lane 2).  Betlp con- 
tains a  six amino acid sequence (RTQLFG) in its NH2 ter- 
minus that is also present in Boslp; consequently, the anti- 
Betlp antibodies  have a  low titer  against Boslp.  Although 
affinity purification against the immune-peptide would not 
select against cross-reacting antibodies, a 9-amino acid pep- 
tide that contains the common sequence RTQLFG efficiently 
competed antibody  recognition of Boslp but  not  Betlp in 
immune-adsorption experiments (see below; Fig. 10 B, corn- 
pare lanes 2 and 3) and ECL-Western blots (not shown). Ad- 
dition  of the  RTQLFG peptide did  not affect the  efficient 
(80%) immuno-isolation of vesicles by anti-Betl  IgG (Fig. 
10  A;  top  insert,  compare lanes  2  and  3),  but  the  Betl 
immune-peptide fully prevented  immune-adsorption (lane 
4). Pre-immune IgG precipitated nothing (not shown). The 
specificity of the anti-Betlp antibody was confirmed in an ex- 
periment described below and in the results shown in Fig. 
10 C (lanes 2-4). In addition, we used antibodies prepared 
against  the  cytoplasmic  domain  of  Sec22p  and  affinity 
purified on nitrocellulose filters that contained E. coli-over- 
produced  Sec22p  fragments.  Anti-Sec22p  antibodies  ad- 
sorbed 84 % of ER-derived transport vesicles to Sepharose 
beads (Fig.  10 A; top insert, lane 5). Although an immune- 
competition experiment was not possible because cytoplas- 
mic fragments of Sec22p were insoluble,  the specificity of 
the antibody was documented by the immunoblot shown in 
Fig.  10 C  (lane 5). 
The protein  composition of vesicles in  immunoisolates 
was examined.  Vesicle proteins were extracted from beads 
with 1% Triton X-100,  resolved by SDS-PAGE, and visual- 
ized by silver stain (Fig. 10 A, gel). The protein composition 
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Figure 11.  Transport vesicles 
form de novo during in vitro 
incubations.  After  stage  I, 
yptlts  membranes  were 
washed  and  aliquoted  into 
tubes that contained the indi- 
cated  components,  to  the 
same  concentration  as  for 
stage  II  (see  Materials  and 
Methods).  Reaction volumes 
were adjusted to 50 #1 with 
B88. To the tubes containing 
no  ATE  we  added  apyrase 
(0.5 U) to hydrolyze residual 
ATP;  these  tubes  were  sup- 
plemented with 50 #M GDP- 
mannose,  normally  added in 
the  ATP  regeneration  mix. 
GTP3,S was added to a con- 
centration of 80 #M. After 35 
min  of incubation  at  25°C, 
perforated  cells  were  sedi- 
merited in a microcentrifuge, 
and vesicles in MSS fractions 
were  immunoisolated  with 
anti-Betlp  antibodies  as  de- 
scribed  in  Fig.  10.  Cytosol 
(180 #g) was used instead of 
an MSS  fraction  for lane  1. 
The  protein  composition  of 
immunoisolates  was  visual- 
ized by silver stain as before. 
of  vesicles immunoisolated with anti-Betl or anti-Sec22 anti- 
bodies was indistinguishable (Fig.  10 A, lanes 2, 3, and 5) 
and clearly distinct from the protein composition of MSS 
fractions (lane 1 ). Immunoisolated vesicles contained all of 
the ERV proteins present in gradient-purified vesicles (Fig. 
10 A, compare lane 6 with lanes 2, 3, and 5), and several 
other abundant proteins. The Betl immune-peptide (Fig.  10 
A, lane 4), but not the RTQLFG peptide (lane 3), prevented 
the adsorption of vesicle proteins to beads. The presence of 
Betlp, Sec22p, Boslp, and coatomer in immunoisolates was 
tested using western blot analysis (Fig. 10, B and C) and the 
relative amount of each protein was compared to that in 0.3 
#g of gradient-purified vesicles (Fig.  10 B, lane 1 ). Triton 
X-100 extracts of  anti-Betlp immunoisolates (Fig. 10 B, lanes 
2 and 3) contained Sec22p, Boslp, core-gp~f, and coatomer. 
Addition  of RTQLFG peptide  to  antibodies  prior to  im- 
munoisolation prevented the  partial  (40%)  adsorption  of 
Boslp by cross-reacting antibodies (Fig. 10 B, compare lanes 
2 and 3), whereas addition of Betl immune-peptide prior to 
immunoisolation fully prevented adsorption of vesicles to 
beads (lane 4).  Antibody-antigen complexes were not ex- 
tracted from beads by Triton X-100, but were subsequently 
extracted with 1% SDS at 65°C (Fig.  10 C). Betlp-IgG pro- 
tein complexes were recovered from beads in SDS extracts 
(Fig. 10 C, lanes 2 and 3), except when Bed-immune peptide 
was mixed with antibodies prior to immunoisolation (lane 
4).  The  Boslp  that  was  adsorbed  onto  beads  by  cross- 
reacting antibodies was also recovered in the SDS extracts 
and  could  be  detected  with  anti-Boslp  antibodies  (not 
shown).  Triton X-100 extracts of anti-Sec22p immunoiso- 
lates contained Betlp, Boslp, core-gptxf, and coatomer (Fig. 
10 B, lane 5),  and Sec22p-IgG complexes were recovered 
from beads in SDS extracts (Fig.  10 C, lane 5). 
Immunoisolation with anti-Betlp antibodies was used to 
examine the requirements for the formation and release of 
vesicles. The release of ER-derived transport vesicles from 
yptl ts perforated cells required cytosol, an ATP regenera- 
tion  system, physiologic temperature,  and  the  absence of 
GTP'yS (Fig.  11 A;  Rexach and Schekman,  1991).  Mem- 
branes that contain ERV proteins were released from per- 
forated cells  with  the  same  biochemical  requirements  as 
ER-derived transport vesicles (Fig. 11 B) and were not pres- 
ent in the cytosol fraction used to promote vesicle budding 
(lane 1). 
Discussion 
We provide a direct biochemical demonstration that diffusi- 
ble vesicles mediate the selective and vectorial transport of 
secretory proteins from ER to Golgi membranes.  This re- 
quired the purification of functional ER-derived transport 
vesicles, assays that reconstitute ER-membrane fusion and 
vesicle fusion with cis-Golgi membranes, and a molecular 
comparison of  transport vesicle and donor membranes to es- 
tablish differences in composition. A  specific inhibitor of 
vesicle targeting was necessary to accumulate ER-derived 
transport vesicles that were amenable to purification, be- 
cause these are only transient intermediates in reconstituted 
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specific antibodies (Rexach and Schekman, 1991) or by mu- 
tation (this study) was suitable, since it had no effect on the 
formation and release of transport vesicles from ER mem- 
branes (Fig. 1), but prevented vesicles from forming stable 
interactions with  Golgi membranes  (Fig.  3).  ER-derived 
transport vesicles that formed in Yptlp-deficient  reactions 
were physically separable from ER and Golgi membranes, 
and were free to diffuse out of perforated cells through holes 
in  the  plasma  membrane.  These  conditions allowed  the 
purification of vesicles which were monitored by their con- 
tent of 35S-core-gpotf. 
Evidence demonstrates that ER-derived transport vesicles 
were purified extensively. First, vesicles that contained pro- 
tease protected core-gpcd were enriched 950-fold from a mix 
of perforated cells and cytosol (Table I). Second, the peak 
of transport vesicles coincided precisely with the peak of 
protein in the last purification step (Fig. 8 A). Third, electron. 
microscopy shows a uniform population of 60 nm vesicles 
with only occasional larger membrane impurities (Fig. 7). 
Finally, protein markers of cytosol, ER, and Golgi mem- 
branes, as well as vacuole, mitochondria, and plasma mem- 
branes, were virtually absent in purified vesicle preparations 
(Table II). 
Several lines of evidence establish the authenticity of the 
purified ER-derived transport vesicles.  Transport vesicles 
contained only ER-modified forms of a  factor and accumu- 
lated only when reconstituted ER to Golgi protein transport 
was blocked by a specific inhibitor (Figs. 1 and 3). Purified 
transport vesicles were 60 nm in size, as are the putative 
transport vesicles that accumulate in vivo in a subset of yeast 
mutant strains that are blocked in ER to Golgi protein trans- 
port (Kaiser and Schekman,  1990).  The vesicles purified 
were not fragments of ER or Golgi membranes because they 
lacked protein markers of these membranes. Vesicles did not 
contain  Sec61p  or  Kar2p;  these  proteins  are  dispersed 
throughout the ER network, mark the ER membrane and lu- 
men, respectively, and function in protein translocation into 
the ER lumen (Stirling et al., 1992; Stirling, C., unpublished 
results; Rose et al., 1989; Preuss et al., 1991; Sanders et al., 
1992).  Vesicles  did not contain GDPase and txl->6 man- 
nosyl-transferase activities; these enzymes reside in early 
compartments of the yeast Golgi complex and are part of the 
glycosylation machinery (Yanagisawa et al., 1990;  Graham 
and Emr,  199t). 
We demonstrate that vesicles purified from Yptlp-deficient 
reactions are vectorial transport intermediates on the basis 
of their ability to fuse with cis-Golgi membranes, but not 
with ER membranes. Diffusible ER-derived transport vesi- 
cles did not fuse with ER membranes under conditions that 
promote ER-membrane fusion (Fig. 6, B and C). Vesicle fu- 
sion with cis-Golgi membranes  was  detected only when 
purified vesicles were mixed with membranes and cytosol 
prepared from a wild-type strain. Fusion was efficient (20 %) 
and required the addition of cytosolic protein, ATE and in- 
cubation at physiologic temperature (Fig. 6,  C and D).  A 
mechanism  that  ensures  the  unldirectionality  of vesicle 
movement is likely to be an integral component of transport 
vesicles. Perhaps the high concentration of Betl, Sec22, and 
Bosl proteins in vesicles relative to donor membranes pre- 
vents "back-fusion" with ER membranes, while promoting 
docking  and  fusion  with cis-Golgi membranes.  Alterna- 
tively, the absence of Kar2p in vesicles may ensure the direc- 
tionality of fusion,  since  Kar2p-function is  required  for 
homotypic ER-membrane fusion (Latterich and Schekman, 
1994). 
Sorting of membrane and lumenal proteins precedes the 
scission of transport vesicles from ER membranes. This fol- 
lows precisely because ER-derived vesicles contained only 
a subset of membrane and lumenal proteins that were ini- 
tially mixed in the ER membrane (Fig. 2). We find that vesi- 
cles contain Betl, Sec22, and Bosl proteins, but not Sec61 
and Kar2  proteins.  The  bulk flow hypothesis (Rothman, 
1987) predicts that the absence of Sec61 and Kar2 proteins 
in vesicles is due to their active retention in the ER mem- 
brane. It will be interesting to determine if core-gpaf, Betlp, 
Sec22p, and Boslp are actively sorted into vesicles during 
budding. Quantitative electron microscopic analysis of im- 
munostained "vesicle buds" on ER membranes should re- 
solve this issue (Bednarek, S., L. Orci, and R. Schekman, 
unpublished results). 
Electron microscopic analysis of thin sections that con- 
tained purified vesicles showed no apparent protein coats 
surrounding  the  vesicle  membrane  (Fig.  7,  C  and  D). 
Nevertheless,  subunits of coatomer were consistently de- 
tected on gradient-purified (see Table 111 and Fig. 10 B, lane 
1) and immunoisolated (Fig. 10 B, lanes 2, 3, and 5) trans- 
port vesicles, but altogether constituted only 1% of the total 
vesicle protein; at this concentration coatomer is probably 
scattered on the vesicle surface. It is likely that ER-derived 
vesicles were initially coated with a protein lattice and lost 
the coat proteins during purification. High molecular weight 
proteins detected in immunoisolated transport vesicles, but 
not in gradient-purified vesicles, may represent components 
of such coats (Fig. 10 A, compare lane 6 to lanes 2, 3, and 
5); these are not subunits of coatomer because equivalent 
amounts of coatomer were detected in gradient-purified as 
well as in -immunoisolated transport vesicles (Fig.  10 B, 
compare lane 1 to lanes 2-4). In other work we have shown 
that coatomer is not required in a reconstituted budding reac- 
tion. Instead, a distinct membrane coat formed by the Sec23/ 
24 complex, the Sec13/31  complex, and Sarlp is found on 
ER-derived transport vesicles produced in the presence of 
nonhydrolyzable analogs of GTP (Barlowe et al., 1994). In- 
terestingly, the gradient-purified transport vesicles described 
here are depleted of coat proteins (see Table III and Fig. 7), 
yet contain the information necessary to target and fuse with 
cis-Golgi membranes (Fig. 6 D); thus, it appears that coat 
proteins need not be maintained on vesicles to retain target- 
ing competence. 
The twelve most abundant proteins in purified ER-derived 
transport vesicles were tightly associated with the vesicle 
membrane and resisted extraction with 1 M potassium ace- 
tate or 0.2 M sodium carbonate at pH 11.5 (Fig. 8 B). These 
proteins were named ERV proteins. Two lines of evidence 
indicate that ERV proteins are components of ER-derived 
transport vesicles. First, the biochemical requirements for 
the release of membranes from perforated cells that contain 
ERV proteins were the same as for transport vesicles that 
contain radiolabeled core-gpoff (Fig. 11). Second, ERV pro- 
teins were abundant in immunoisolated transport vesicles, as 
well as gradient-purified vesicles (Fig. 10 A; compare lanes 
2, 3, and 5 to lane 6). None of the identified ERV proteins 
is Betl or Sec22 proteins since their absence in Triton X-100 
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10 B, compare lane I to lanes 2 and 5) does not result in the 
absence of an ERV protein (evidenced by silver stain;  Fig. 
10 A, compare lane 6to lanes 2, 3, and 5). It remains to be 
determined whether ERV proteins and less abundant pro- 
teins in purified vesicle fractions (Fig.  8) play a functional 
role in vesicular transport,  or are just cargo. 
Three lines of evidence confirm the presence of core-gl~f, 
Betl, Sec22, and Bosl proteins in the same transport vesi- 
cles. First, the kinetics of release from perforated cells of 
membranes  that  contained  Betlp,  Sec22p,  and  core-gl~f 
were almost identical,  as expected for proteins that reside in 
the same vesicle population (Fig.  2). Second, vesicles that 
were purified in gradients were highly  enriched in all four 
proteins (Table III and Fig.  10 B, lane 1 ). The fold enrich- 
merit of Betlp, Sec22p,  and Boslp at each purification  step 
was comparable. Nevertheless,  vesicles that contain most of 
Sec22 and Bosl proteins were slightly  denser (31% wt/wt) 
than  the  average  Betlp and  core-gpaf containing  vesicle 
(30% wt/wt) in sucrose equilibrium density gradients  (not 
shown).  The small discrepancy in densities  can best be ex- 
plained by two possibilities;  either these proteins are present 
in different types of ER-derived vesicles, or vesicles contain 
unequal amounts of all three proteins,  which may influence 
vesicle density. To better determine whether proteins reside 
in the same vesicles or not, we used antibodies that recognize 
Betlp  or  Sec22p to  immunoisolate  ER-derived  transport 
vesicles from MSS fractions with the premise that,  if Betlp, 
Sec22p,  Boslp, and core-gl~f reside in separate vesicles, 
they should not all be present in specific  immunoisolates. 
Antibodies  against  Betlp,  and  antibodies against  Sec22p, 
efficiently precipitated vesicles that contain all four proteins 
(Fig. 10, lanes 2, 3, and 5); the relative ratio of these proteins 
with respect to each other was similar in vesicles purified in 
gradients or isolated in immuno-beads (Fig.  10 B; compare 
lane I with lanes'2, 3, and 5). These results are in disagree- 
ment with those obtained by Lian et al. (1993) who reported 
that ER-derived transport vesicles lack detectable amounts 
of  Betlp. This discrepancy may relate to the presence of func- 
tional Yptlp in their vesicle budding reaction.  Perhaps Yptlp 
serves to regulate the packaging of certain vesicle membrane 
proteins and in its absence Betlp may be gathered into a bud. 
This role in protein segregation  cannot be essential because 
vesicles purified from Yptl-deficient reactions are competent 
to target and fuse with cis-Golgi membranes (Fig. 6, C and 
D) in a reaction that requires Yptlp-function  (Rexach,  M., 
unpublished results). In normal reactions, Yptl protein may 
become associated with transport vesicles during  the bud- 
ding reaction, however it is clear that this timing is not ob- 
ligate and vesicles formed in the absence of Yptlp may ac- 
quire this  protein  in the course of targeting  to the Golgi 
complex. 
The finding that Betlp, Sec22p,  Boslp, and coatomer are 
components of ER-derived transport vesicles, and the avail- 
able genetic evidence on the various interactions  between 
genes that encode these proteins (reviewed  in Pryer et al., 
1992),  suggests  a  physical  interaction  between these pro- 
teins. We propose a model in which Sec22, Betl, and Bosl 
interact to form part of a docking complex that specifies and 
promotes  the  stable  attachment  of vesicles  to  cis-Golgi 
membranes. Coatomer may function to concentrate docking 
complexes in vesicles,  or may mask active docking sites on 
the vesicle surface. Yptlp may monitor the subunit composi- 
tion of docking complexes in ER-derived transport vesicles 
to promote vesicle attachment to cis-Golgi membranes. 
The availability  of functional  ER-derived transport vesi- 
cles in highly purified form, combined with a cell-free assay 
that measures vesicle fusion with cis-Golgi membranes, will 
facilitate the further dissection of the mechanisms of vesicle 
targeting and membrane fusion.  Because reconstituted vesi- 
cle fusion requires the addition of cytosolic factors, this pro- 
vides a biochemical assay for the purification  of soluble pro- 
teins that function at this stage. The generation  of antibodies 
against surface constituents  of transport vesicles should pro- 
vide the tools necessary to examine the function of ERV pro- 
teins in reconstituted transport.  The identification  of genes 
that encode the ERV proteins should allow an assessment of 
their function in living  cells. 
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